INFINITE received a research grant by Mallinckrodt Pharmaceuticals

Tackling fibrosis in inflammatory disorders is one of the important goal of our team!

INFINITE has received a research grant by Mallinckrodt Pharmaceuticals to study the role and mechanisms of Extracorporeal photopheresis in treatment of fibrosis in an experimental model of systemic sclerosis.